• Treating Myasthenia Gravis? Don't Stop at Pyridostigmine

  • Jun 22 2023
  • Length: 19 mins
  • Podcast

Treating Myasthenia Gravis? Don't Stop at Pyridostigmine cover art

Treating Myasthenia Gravis? Don't Stop at Pyridostigmine

  • Summary

  • Drs Nicholas Silvestri and Neelam Goyal lay out pathways for successful routine treatment of myasthenia gravis.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990458). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Adverse Side Effects Associated With Corticosteroid Therapy: A Study in 39 Patients With Generalized Myasthenia Gravis https://pubmed.ncbi.nlm.nih.gov/34707081/

    The History of Acetylcholinesterase Inhibitors in the Treatment of Myasthenia Gravis https://pubmed.ncbi.nlm.nih.gov/32918950/

    FcRn Inhibitors: A Novel Option for the Treatment of Myasthenia Gravis https://pubmed.ncbi.nlm.nih.gov/36751773/

    Ravulizumab: A Review in Generalised Myasthenia Gravis https://pubmed.ncbi.nlm.nih.gov/37166620/

    Safety and Efficacy of Eculizumab in Anti-acetylcholine Receptor Antibody-positive Refractory Generalised Myasthenia Gravis (REGAIN): A Phase 3, Randomised, Double-blind, Placebo-controlled, Multicentre Study https://pubmed.ncbi.nlm.nih.gov/29066163/

    Show More Show Less

What listeners say about Treating Myasthenia Gravis? Don't Stop at Pyridostigmine

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.